Loss of EMI1 compromises chromosome stability and is associated with cellular transformation in colonic epithelial cell contexts

Br J Cancer. 2024 Nov;131(9):1516-1528. doi: 10.1038/s41416-024-02855-9. Epub 2024 Oct 2.

Abstract

Background: Colorectal cancer (CRC) is still a leading cause of cancer deaths worldwide. Thus, identifying the aberrant genes and proteins underlying disease pathogenesis is critical to improve early detection methods and develop novel therapeutic strategies. Chromosome instability (CIN), or ongoing changes in chromosome complements, is a predominant form of genome instability. It is a driver of genetic heterogeneity found in ~85% of CRCs. Although CIN contributes to CRC pathogenesis, the molecular determinants underlying CIN remain poorly understood. Recently, EMI1, an F-box protein, was identified as a candidate CIN gene. In this study, we sought to determine the impact reduced EMI1 expression has on CIN and cellular transformation.

Methods: Coupling siRNA-based silencing and CRISPR/Cas9 knockout clones with quantitative imaging microscopy we evaluated the impact reduced EMI1 expression has on CIN and cellular transformation in four colonic epithelial cell contexts.

Results: Quantitative imaging microscopy data revealed that reduced EMI1 expression induces increases in CIN phenotypes in both transient (siRNA) and constitutive (CRISPR/Cas9) cell models that are associated with increases in DNA damage and cellular transformation phenotypes in long-term studies.

Conclusions: This study determined that reduced EMI1 expression induces CIN and promotes cellular transformation, which is consistent with a role in early CRC development.

MeSH terms

  • CRISPR-Cas Systems
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic* / genetics
  • Chromosomal Instability*
  • Colon / metabolism
  • Colon / pathology
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / metabolism
  • Colorectal Neoplasms / pathology
  • DNA Damage
  • Epithelial Cells* / metabolism
  • Epithelial Cells* / pathology
  • Humans
  • RNA, Small Interfering / genetics

Substances

  • RNA, Small Interfering
  • FBXO5 protein, human